Todd R. Brady
CIK: 0001767644
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CTNM
Contineum Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Brady Todd R.
Brady Todd R. (SEC CIK 0001767644) files insider reports with the SEC as Director of Contineum Therapeutics, Inc. (CTNM).
Signal8 holds 2 ownership filings by Brady Todd R., all Form 4s, filed between Jun 26, 2025 and Jun 26, 2026. Those filings report 2 transactions, from Jun 26, 2025 to Jun 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Brady Todd R.'s filings is in SAN DIEGO, CA.
Recent filings by Brady Todd R.
Other insiders filing for Contineum Therapeutics, Inc. (CTNM)
- Stengone Carmine N., CEO and President
- Lorrain Daniel S., Chief Scientific Officer
- Watkins Tim, CMO & Head of Development
- Miralles Gines Diego, Director
- Lyons-Williams Lori, Director
- Ware Olivia C, Director